Ono Pharmaceutical
Mr. Gyo Sagara (CEO, Pres & Representative Director)
Mr. Shozo Matsuoka Ph.D. (Corp. Exec. Officer and Exec. Director of Corp. Regulatory Compliance, Safety & QA)
Yukio Tani (Corp. Exec. Officer & Head of Corp. Communications)
Summary
History
Ono Pharmaceutical Co., Ltd. (??????????, Ono Yakuhin K?gy? Kabushiki-gaisha) is one of the largest pharmaceutical companies in Japan. It is headquartered in Chuo-ku, Osaka, Japan, with its major plants in Higashinari-ku, Osaka, and Fujinomiya, Shizuoka., and its central research institute at Minase, Shimamoto-cho, Mishima District, Osaka.
Ono Pharmaceutical's roots go back to 1717 when Ichibei Ono (Japanese: ?????) started his dealer business of pharmaceuticals in Osaka. His business expanded and changed its name a few times, and became Ono Pharmaceutical Industrial Co., Ltd. (Japanese: ??????????) in 1948.
Ono has been listed in Tokyo Stock Exchange since 1963. Its consolidated earnings in the half year ending in March 2018 were 16 billion Japanese yen.
Mission
Vision
Key Team
Katsuji Teranishi (Corp. Officer and Chief Officer of Sales, Mkt, Wholesales Mgt., Planning & Primary Care Bus. Div.)
Mr. Isao Ono (Exec. Officer, Director of Corp. Research & Director)
Mr. Hiroshi Ichikawa (Corp. Officer & Sr. Director of Medical External Affairs)
Mr. Toshihiro Tsujinaka (Sr. Exec. Officer, Exec. Director of Corp. Strategy & Planning and Director)
Mr. Toichi Takino Ph.D. (Sr. Exec. Officer, Exec. Director of Discovery & Research and Director)
Hiromu Habashita Ph.D. (Corp. Officer and Deputy Exec. Director of Discovery & Research Division)
Kiyoaki Idemitsu (Exec. Officer, Exec. Director of Clinical Devel. & Director)
Recognition and Awards
References
Mr. Gyo Sagara (CEO, Pres & Representative Director)
Mr. Shozo Matsuoka Ph.D. (Corp. Exec. Officer and Exec. Director of Corp. Regulatory Compliance, Safety & QA)
Yukio Tani (Corp. Exec. Officer & Head of Corp. Communications)
